1. Home
  2. DRI vs UTHR Comparison

DRI vs UTHR Comparison

Compare DRI & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Darden Restaurants Inc.

DRI

Darden Restaurants Inc.

SELL

Current Price

$231.56

Market Cap

22.4B

ML Signal

SELL

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

SELL

Current Price

$583.32

Market Cap

23.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DRI
UTHR
Founded
1968
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.4B
23.9B
IPO Year
2000
1999

Fundamental Metrics

Financial Performance
Metric
DRI
UTHR
Price
$231.56
$583.32
Analyst Decision
Buy
Buy
Analyst Count
28
15
Target Price
$233.44
★ $687.14
AVG Volume (30 Days)
★ 817.5K
449.2K
Earning Date
12-17-2026
11-04-2026
Dividend Yield
★ 2.81%
N/A
EPS Growth
★ 17.16
13.07
EPS
2.04
★ 18.80
Revenue
★ $13,210,900,000.00
$1,483,300,000.00
Revenue This Year
$3.73
$2.40
Revenue Next Year
$6.07
$10.58
P/E Ratio
$113.23
★ $31.27
Revenue Growth
★ 9.39
2.38
52 Week Low
$169.00
$455.63
52 Week High
$233.98
$614.23

Technical Indicators

Market Signals
Indicator
DRI
UTHR
Relative Strength Index (RSI) 65.00 52.92
Support Level $191.40 $559.33
Resistance Level $231.87 $586.61
Average True Range (ATR) 5.37 18.22
MACD 0.33 -2.82
Stochastic Oscillator 81.92 42.10

Price Performance

Historical Comparison
DRI
UTHR

About DRI Darden Restaurants Inc.

Darden Restaurants is the largest global full-service dining operator, with over $13 billion in system sales across 2,202 company-owned stores at the end of fiscal 2026, spanning the US and Canada. The firm operates 10 banners in four segments, including Olive Garden (42% of sales), LongHorn Steakhouse (26%), and fine dining (21%), which includes The Capital Grille, Ruth's Chris, and Eddie V's. The other 11% of sales comes from smaller concepts such as Yard House and Cheddar's. Darden primarily generates revenue through sales of food and beverage items at its company-owned restaurants. It also earns royalties on sales from 167 franchised locations in US and international markets, which sit within the other segment but are immaterial to consolidated results.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: